# Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis

> **NCT05033639** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ilocos Training and Regional Medical Center** · enrollment: 100 (actual)

## Conditions studied

- Necrotizing Enterocolitis

## Interventions

- **DRUG:** Melatonin 6 MG
- **OTHER:** Breast Milk

## Key facts

- **NCT ID:** NCT05033639
- **Lead sponsor:** Ilocos Training and Regional Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05033639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05033639, "Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05033639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*